Why Moderna Could Actually Be a Value Stock

This isn't an April Fools' Day joke. Moderna (NASDAQ: MRNA) could be viewed as a value stock. Seriously.

I know what you're probably thinking: How can a stock with a market cap of over $51 billion with sales of only around $800 million last year even remotely qualify as a bargain? You might be surprised to learn how strong the case for Moderna as a value stock is.

Image source: Getty Images.

Continue reading

Source Fool.com